Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1878092

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1878092

U.S. Probiotics Market - Forecasts from 2025 to 2030

PUBLISHED:
PAGES: 82 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2850
PDF (Multiple User License)
USD 3450
PDF (Enterprise License)
USD 5850

Add to Cart

The U.S. probiotics market, at a 10.85% CAGR, is expected to grow to USD 21.510 billion in 2030 from USD 12.852 billion in 2025.

The analytical journey begins with a macro-level assessment of the country's overall context. This foundational segment examines key national indicators, including prevailing demographic trends, the current economic scenario, the political environment, stock market movements, and international trade dynamics. This broad overview establishes the essential background against which the specific probiotics market operates, identifying overarching national trends that could influence business conditions, consumer purchasing power, and regulatory directions.

Building upon this national context, the report then delves into a comprehensive analysis of the U.S. dairy industry, a critical sector for probiotic applications. This segment provides an exhaustive picture of the industry's outlook, detailing factors such as milk production volumes and the domestic supply-demand scenario. It further explores the market's technological advancements, key industry policies and regulations, and the landscape of industry participants and major market players. A thorough examination of the overall dairy industry regulatory framework is included, offering stakeholders critical insights into the compliance environment and the key factors shaping the market ecosystem for dairy-based probiotics.

The analysis of the investment climate forms a core component of the report. This segment provides a dedicated investment analysis, which includes an overview of recent market deals, foreign direct investment (FDI) regulations, and significant proposals and memoranda of understanding (MoUs). To gauge market sentiment and corporate performance, the stock movement of key publicly traded players in the sector is also evaluated. This financial and transactional perspective is further enriched by incorporating the outlook on the U.S. dairy industry from major international bodies such as the World Bank and the United Nations, providing a globally-informed perspective on the sector's trajectory.

Recognizing the integral role of probiotics within the broader functional foods category, the report includes a dedicated segment analyzing the U.S. functional food market. This analysis covers the primary market drivers and emerging opportunities, as well as the challenges facing the sector. It assesses the market size and provides a forecast for its development. Furthermore, this segment details the specific policies, regulations, and government subsidies and investments that are shaping the functional food landscape, thereby contextualizing the position of probiotic products within this high-growth category.

The report culminates in a focused outlook on the U.S. probiotics market itself. This segment provides detailed metrics and analysis, including market size, a retail sector outlook, and an overview of recent market initiatives. It incorporates competitive intelligence to illuminate the strategies and positions of key players in the space. An important consideration for potential entrants and existing players, the total cost of ownership for probiotic products and operations is also analyzed. To facilitate efficient comprehension, the findings throughout the report are supported by clear presentations, charts, and graphics.

The final segment is forward-looking, providing a future outlook for the U.S. probiotics market. This concluding analysis synthesizes the information from all previous segments to project the business opportunities that lie ahead, offering a clear and strategic picture of the sector's potential for investors and industry participants. The report, through its structured and layered approach, serves as a definitive guide for understanding the complex, multi-sectoral business environment for probiotics in the United States.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

SEGMENTATION

  • UNITED STATES PROBIOTICS MARKET BY INGREDIENT
  • Bacteria
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus Thermophilus
  • Yeast
  • Saccharomyces Boulardii
  • Others
  • UNITED STATES PROBIOTICS MARKET BY FORM
  • Liquid
  • Dry
  • UNITED STATES PROBIOTICS MARKET BY APPLICATION
  • Functional Food and Beverages
  • Dietary Supplements
  • Animal Feed
  • UNITED STATES PROBIOTICS MARKET BY END-USER
  • Human
  • Animal
  • UNITED STATES PROBIOTICS MARKET BY COUNTRY
  • USA
  • Canada
  • Mexico
Product Code: KSI061610949

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. UNITED STATES PROBIOTICS MARKET BY INGREDIENT

  • 5.1. Introduction
  • 5.2. Bacteria
    • 5.2.1. Lactobacilli
    • 5.2.2. Bifidobacterium
    • 5.2.3. Streptococcus Thermophilus
  • 5.3. Yeast
    • 5.3.1. Saccharomyces Boulardii
    • 5.3.2. Others

6. UNITED STATES PROBIOTICS MARKET BY FORM

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Dry

7. UNITED STATES PROBIOTICS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Functional Food and Beverages
  • 7.3. Dietary Supplements
  • 7.4. Animal Feed

8. UNITED STATES PROBIOTICS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Human
  • 8.3. Animal

9. UNITED STATES PROBIOTICS MARKET BY COUNTRY

  • 9.1. Introduction
  • 9.2. USA
  • 9.3. Canada
  • 9.4. Mexico

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Yakult Honsha Co., Ltd.
  • 11.2. Kerry Group Plc.
  • 11.3. Danone
  • 11.4. Nestle
  • 11.5. Probi
  • 11.6. Lifeway Foods, Inc
  • 11.7. Archer Daniels Midland Company
  • 11.8. General Mills, Inc
  • 11.9. BioGaia USA, Inc.
  • 11.10. Procter & Gamble Co.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!